In Vitro: Inhibits cell viability and induced apoptosis, increasing the expression of apoptosis-related proteins, while promoting ERS via upregulation of GRP78 and IRE1. In Vivo: Reduced tumor weight and growth in LLC mice, enhanced apoptosis markers. The gene discussed is ERN1; the disease is neoplasm.